DePuy Orthopaedics, Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2005 | private lawsuit-federal | $15,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2004 | private lawsuit-federal | $90,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $45,000,000 |
Janssen Pharmaceuticals | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | WV-AG | $99,000,000 |
Depuy Synthes Sales, Inc. | Johnson & Johnson | wage and hour violation | 2020 | CA-LCO | $57,488 |
Janssen Pharmaceuticals/Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | product safety violation | 2022 | private lawsuit-federal | $150,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
DePuy Synthes, Inc. | Johnson & Johnson | False Claims Act and related | 2023 | DOJ_CIVIL | $9,750,000 |
Ethicon | Johnson & Johnson | consumer protection violation | 2023 | KY-AG | $9,900,000 |
Johnson & Johnson Vision Care Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $55,000,000 |
Momenta Pharmaceuticals Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $35,000,000 |
Johnson & Johnson | Johnson & Johnson | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $25,000,000 |
Johnson & Johnson | Johnson & Johnson | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
Johnson and Johnson | Johnson & Johnson | product safety violation | 2023 | CA-AG | $302,000,000 |
Johnson & Johnson | Johnson & Johnson | consumer protection violation | 2020 | private lawsuit-federal | $6,315,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2019 | private lawsuit-federal | $2,400,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $6,750,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2017 | private lawsuit-federal | $5,000,000 |
Neutrogena Corporation | Johnson & Johnson | consumer protection violation | 2013 | private lawsuit-federal | $1,800,000 |
Johnson & Johnson, Inc. | Johnson & Johnson | insurance violation | 2020 | NC-INS | $150,000 |
STERILMED, INC. | Johnson & Johnson | workplace safety or health violation | 2006 | OSHA | $11,278 |
ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2017 | OSHA | $6,518 |
DEPUY SYNTHES PRODUCTS, LLC | Johnson & Johnson | workplace safety or health violation | 2018 | OSHA | $5,654 |
JOHNSON & JOHNSON CONSUMER, INC. | Johnson & Johnson | workplace safety or health violation | 2018 | OSHA | $7,853 |
DEPUY SYNTHES | Johnson & Johnson | workplace safety or health violation | 2019 | OSHA | $5,000 |
ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2020 | OSHA | $9,832 |
DEPUY SYNTHES PRODUCTS, INC. | Johnson & Johnson | workplace safety or health violation | 2022 | OSHA | $7,044 |
Janssen Pharmaceutical (SB) | Johnson & Johnson | environmental violation | 2010 | EPA | $105,000 |
DePuy Synthes | Johnson & Johnson | environmental violation | 2019 | EPA | $51,750 |
Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
Janssen Pharmaceutica Inc. | Johnson & Johnson | environmental violation | 2004 | EPA | $7,700 |
Johnson & Johnson | Johnson & Johnson | environmental violation | 2004 | EPA | $5,000 |
Jazz Pharmaceuticals Inc. | Jazz Pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | USAO | $20,000,000 |
Jazz Pharmaceuticals plc | Jazz Pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $57,000,000 |
Indivior Solutions | Indivior PLC | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
Indivior, Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2020 | FTC | $10,000,000 |
Indivior plc | Indivior PLC | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $300,000,000 |
Indivior Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
Incyte Corporation | Incyte Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $12,600,000 |
IDEXX Laboratories, Inc. | IDEXX Laboratories | employment discrimination | 2020 | OFCCP | $200,000 |
IDEXX Reference Laboratories, Inc. | IDEXX Laboratories | environmental violation | 2009 | AZ-DEQ | $80,000 |
IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | workplace safety or health violation | 2017 | OSHA | $9,600 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
General Nutrition Corporation | Harbin Pharmaceutical Group | wage and hour violation | 2017 | MA-AG | $72,304 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2015 | private lawsuit-federal | $350,014 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-federal | $60,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
General Nutrition Corp. | Harbin Pharmaceutical Group | consumer protection violation | 2002 | FL-AG | $1,000,000 |
General Nutrition Corporation | Harbin Pharmaceutical Group | employment discrimination | 2019 | private lawsuit-federal | $550,187 |
GNC | Harbin Pharmaceutical Group | employment discrimination | 2019 | NY-NYCCHR | $35,000 |
General Nutrition Centers Inc. | Harbin Pharmaceutical Group | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
GENERAL NUTRITION CORPORATION | Harbin Pharmaceutical Group | workplace safety or health violation | 2019 | OSHA | $7,674 |
GNC HOLDINGS LLC | Harbin Pharmaceutical Group | workplace safety or health violation | 2022 | OSHA | $6,720 |
GNC HOLDINGS INC. | Harbin Pharmaceutical Group | workplace safety or health violation | 2023 | OSHA | $17,858 |
Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
GlaxoSmithKline Vaccines | GlaxoSmithKline | environmental violation | 2014 | EPA | $172,900 |
GlaxoSmithKline LLC | GlaxoSmithKline | environmental violation | 2014 | EPA | $317,550 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
GlaxoSmithKline plc | GlaxoSmithKline | kickbacks and bribery | 2016 | SEC | $20,000,000 |
Block Drug Company Incorporated | GlaxoSmithKline | wage and hour violation | 2011 | WHD | $352,773 |
SmithKline Beecham | GlaxoSmithKline | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
GLAXO SMITH KLINE | GlaxoSmithKline | aviation safety violation | 2014 | FAA | $59,500 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | kickbacks and bribery | 2014 | MULTI-AG | $105,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | tax violations | 2006 | IRS | $3,400,000,000 |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | environmental violation | 2016 | PA-ENV | $5,259 |